MGX Stock Analysis: Buy, Sell, or Hold?
MGX - Metagenomi, Inc. Common Stock
$1.28
-0.05 (-3.76%)
▼
5d:
-5.88%
30d:
-10.49%
90d:
-13.51%
HOLD
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When MGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MGX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MGX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MGX is currently trading at $1.28, which is considered oversold relative to its 30-day fair value range of $1.30 to $1.40.
Technical Outlook: Technically, MGX is in a strong downtrend. The price is currently testing key support at $1.25. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+525.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MGX is in a strong downtrend. The price is currently testing key support at $1.25. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+525.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.30 -
$1.40
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 525.0% below Wall St target ($8.00)
- CAUTION: Recommendation downgraded due to -5.9% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.30 -
$1.40
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.25
Resistance Level
$1.42
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.70
Wall Street Target
$8.00
(+525.0%)
Revenue Growth (YoY)
-69.8%
Share & Embed Analysis
Last updated: June 06, 2026 10:31 AM ET
Data refreshes hourly during market hours. Next update: 11:31 AM
Data refreshes hourly during market hours. Next update: 11:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Pamela Wapnick
SELL
1581 shares
2026-03-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 61 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$183 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$126 | 58 HOLD |
